SCHEDULE: Adage Capital Discloses 5.68% Stake in EyePoint Inc.

Adage Capital Management, L.P. and its principals have reported a 5.68% beneficial ownership stake in EyePoint, Inc., holding 4,700,000 shares as of December 31, 2025.

Summary

• Adage Capital Management, L.P., Robert Atchinson, and Phillip Gross collectively reported beneficial ownership of 4,700,000 shares of EyePoint, Inc. Common Stock.
• This ownership represents 5.68% of EyePoint, Inc.'s outstanding Common Stock.
• The percentage is calculated based on 82,787,220 shares of Common Stock outstanding as of October 30, 2025, as reported in EyePoint, Inc.'s Form 10-Q filed on November 6, 2025.
• The filing is an Amendment No. 6 to Schedule 13G, indicating a previous disclosure of ownership.
• The Reporting Persons hold shared voting power and shared dispositive power over all 4,700,000 shares.
• The securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive signal. The continued significant beneficial ownership by a reputable institutional investor like Adage Capital Management suggests ongoing confidence in EyePoint, Inc., although it is an amendment and not a new entry.

Positives

• A significant institutional investor, Adage Capital Management, L.P., maintains a substantial 5.68% stake in EyePoint, Inc., signaling continued confidence in the company's prospects.
• The investment is stated to be in the ordinary course of business, suggesting a long-term investment strategy rather than an activist position.

Risks

• The filing includes a standard disclaimer that it should not be construed as an admission by any Reporting Person as to beneficial ownership of the securities reported herein.

Future Outlook

The filing does not contain any forward-looking statements or guidance from EyePoint, Inc. or the Reporting Persons regarding the issuer's future performance.

Management Comments

• "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §§ 240.14a-11."

Industry Context

StockSavvy.ai notes that Schedule 13G filings are routine disclosures by institutional investors who acquire more than 5% of a company's stock, but do not intend to influence or change control of the company. The continued significant stake by Adage Capital Management, a prominent hedge fund, suggests a sustained investment thesis in EyePoint, Inc. within the biotechnology or pharmaceutical sector.

Comparison to Industry Standards

• Adage Capital Management, L.P. is a well-established hedge fund known for its rigorous due diligence and long-term investment horizon, particularly in the healthcare and technology sectors. Their continued holding of a significant stake in EyePoint, Inc. aligns with typical institutional investment strategies for promising biotech firms.
• A 5.68% stake is a material position for an institutional investor, indicating a high level of conviction in EyePoint, Inc. compared to smaller, more speculative positions often seen in emerging companies.

Stakeholder Impact

• Shareholders may view the continued significant institutional ownership by Adage Capital Management as a positive indicator of the company's value and future prospects, potentially bolstering investor confidence.
• The company's management might interpret this as a vote of confidence from a sophisticated investor, which could support strategic decisions and future capital-raising efforts.

Key Dates

Recommendation

A seasoned investor would interpret Adage Capital Management's continued 5.68% beneficial ownership in EyePoint, Inc. as a strong vote of confidence from a major institutional player. This sustained significant stake, particularly from a fund known for its thorough research, suggests a positive long-term outlook for the company. While it's an amendment and not a new position, the maintenance of such a substantial holding indicates that Adage Capital sees continued value, making EyePoint, Inc. an attractive 'buy' for investors seeking institutional backing.

Keywords

EyePoint Inc., Adage Capital Management, Beneficial Ownership, Schedule 13G, Institutional Investment, Common Stock, EYPT, Robert Atchinson, Phillip Gross